Craig A. Erickson

10.9k total citations
158 papers, 4.3k citations indexed

About

Craig A. Erickson is a scholar working on Cognitive Neuroscience, Genetics and Psychiatry and Mental health. According to data from OpenAlex, Craig A. Erickson has authored 158 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 134 papers in Cognitive Neuroscience, 92 papers in Genetics and 57 papers in Psychiatry and Mental health. Recurrent topics in Craig A. Erickson's work include Autism Spectrum Disorder Research (129 papers), Genetics and Neurodevelopmental Disorders (89 papers) and Attention Deficit Hyperactivity Disorder (37 papers). Craig A. Erickson is often cited by papers focused on Autism Spectrum Disorder Research (129 papers), Genetics and Neurodevelopmental Disorders (89 papers) and Attention Deficit Hyperactivity Disorder (37 papers). Craig A. Erickson collaborates with scholars based in United States, China and Australia. Craig A. Erickson's co-authors include Christopher J. McDougle, Logan Wink, David J. Posey, Ernest V. Pedapati, Kimberly A. Stigler, Kelli C. Dominick, Rebecca C. Shaffer, Jennifer Mullett, John A. Sweeney and Lauren Schmitt and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Neuroscience.

In The Last Decade

Craig A. Erickson

149 papers receiving 4.2k citations

Peers

Craig A. Erickson
Elaine Tierney United States
Ruth K. Abramson United States
Keun‐Ah Cheon South Korea
Cristan Farmer United States
Ziarih Hawi Ireland
Bob Oranje Denmark
A.J. Richardson United Kingdom
Elaine Tierney United States
Craig A. Erickson
Citations per year, relative to Craig A. Erickson Craig A. Erickson (= 1×) peers Elaine Tierney

Countries citing papers authored by Craig A. Erickson

Since Specialization
Citations

This map shows the geographic impact of Craig A. Erickson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig A. Erickson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig A. Erickson more than expected).

Fields of papers citing papers by Craig A. Erickson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig A. Erickson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig A. Erickson. The network helps show where Craig A. Erickson may publish in the future.

Co-authorship network of co-authors of Craig A. Erickson

This figure shows the co-authorship network connecting the top 25 collaborators of Craig A. Erickson. A scholar is included among the top collaborators of Craig A. Erickson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig A. Erickson. Craig A. Erickson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blank, Elizabeth, Donald L. Gilbert, Steve W. Wu, et al.. (2024). Accelerated Theta Burst Transcranial Magnetic Stimulation for Refractory Depression in Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. 55(3). 940–954. 3 indexed citations
2.
Erickson, Craig A., Rebecca C. Shaffer, Lauren Schmitt, et al.. (2023). Brief Report: A Double-Blind, Placebo-Controlled, Crossover, Proof-of-Concept Study of Minocycline in Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. 55(9). 3387–3394. 3 indexed citations
3.
Pedapati, Ernest V., Lauren Schmitt, Rebecca C. Shaffer, et al.. (2023). Reliability of resting-state electrophysiology in fragile X syndrome. SHILAP Revista de lepidopterología. 9. 100070–100070. 4 indexed citations
4.
Kang, Sung‐Eun, et al.. (2023). Behavioral inflexibility in fragile X syndrome: Accounts from caregivers and self-advocates. Frontiers in Psychology. 14. 1118652–1118652. 2 indexed citations
5.
Schmitt, Lauren, Gunvant Chaudhari, Ernest V. Pedapati, et al.. (2023). Hypersensitivity to Distractors in Fragile X Syndrome from Loss of Modulation of Cortical VIP Interneurons. Journal of Neuroscience. 43(48). 8172–8188. 4 indexed citations
6.
Pedapati, Ernest V., Kelli C. Dominick, Martine Lamy, et al.. (2023). Patterns in Medication Use for Treatment of Depression in Autistic Spectrum Disorder. Journal of Autism and Developmental Disorders. 55(6). 1969–1975.
7.
Pedapati, Ernest V., Lauren Schmitt, Lauren E. Ethridge, et al.. (2022). Neocortical localization and thalamocortical modulation of neuronal hyperexcitability contribute to Fragile X Syndrome. Communications Biology. 5(1). 442–442. 24 indexed citations
8.
Berry‐Kravis, Elizabeth, Randi J. Hagerman, Dejan B. Budimirovic, et al.. (2022). A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX). Journal of Neurodevelopmental Disorders. 14(1). 56–56. 39 indexed citations
9.
Albizua, Igor, Krista Charen, Lisa Shubeck, et al.. (2022). Descriptive analysis of seizures and comorbidities associated with fragile X syndrome. Molecular Genetics & Genomic Medicine. 10(8). e2001–e2001. 4 indexed citations
10.
Smith, Elizabeth G., Ernest V. Pedapati, Lauren Schmitt, et al.. (2021). Sex differences in resting EEG power in Fragile X Syndrome. Journal of Psychiatric Research. 138. 89–95. 26 indexed citations
11.
Lamy, Martine, et al.. (2021). Decades of Progress in the Psychopharmacology of Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. 51(12). 4370–4394. 19 indexed citations
12.
Dominick, Kelli C., Howard Andrews, Walter E. Kaufmann, Elizabeth Berry‐Kravis, & Craig A. Erickson. (2021). Psychotropic Drug Treatment Patterns in Persons with Fragile X Syndrome. Journal of Child and Adolescent Psychopharmacology. 31(10). 659–669. 10 indexed citations
13.
Wink, Logan, Paul S. Horn, Rebecca C. Shaffer, et al.. (2020). Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder—Initial Results of a Randomized, Controlled, Crossover, Pilot Study. Journal of Autism and Developmental Disorders. 51(4). 1392–1399. 19 indexed citations
14.
Fitzpatrick, Sarah E., Lauren Schmitt, Ryan Adams, et al.. (2019). Pediatric Quality of Life Inventory (PedsQL) in Fragile X Syndrome. Journal of Autism and Developmental Disorders. 50(3). 1056–1063. 5 indexed citations
15.
Dominick, Kelli C., Logan Wink, Ernest V. Pedapati, et al.. (2018). Risperidone Treatment for Irritability in Fragile X Syndrome. Journal of Child and Adolescent Psychopharmacology. 28(4). 274–278. 10 indexed citations
16.
Wink, Logan, Ryan Adams, Zemin Wang, et al.. (2016). A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder. PMC.
17.
Wink, Logan, et al.. (2016). Weight Gain Effects of Second-Generation Antipsychotic Treatment in Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. 26(9). 822–827. 35 indexed citations
18.
Wink, Logan, Ernest V. Pedapati, Paul S. Horn, Christopher J. McDougle, & Craig A. Erickson. (2015). Multiple Antipsychotic Medication Use in Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. 27(1). 91–94. 18 indexed citations
19.
Wink, Logan, Maureen Early, Tori L. Schaefer, et al.. (2014). Body Mass Index Change in Autism Spectrum Disorders: Comparison of Treatment with Risperidone and Aripiprazole. Journal of Child and Adolescent Psychopharmacology. 24(2). 78–82. 58 indexed citations
20.
Erickson, Craig A., Maureen Early, Kimberly A. Stigler, et al.. (2011). An Open-Label Naturalistic Pilot Study of Acamprosate in Youth with Autistic Disorder. Journal of Child and Adolescent Psychopharmacology. 21(6). 565–569. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026